Elders stock heads toward November 16 results after EBIT growth

Published on 10/07/2026 at 01:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elders stock carries AUD 76.6 million of first-half core EBIT growth into the November 16 results date. Eight analysts set an average target of AUD 6.56.

Elders, AU000000ELD6, Illustration mit AI erstellt.

Elders Limited (ISIN AU000000ELD6) was trading at AUD 6.32 on the ASX on October 7, 2026, down 0.16 percent from the prior close and giving the company a market capitalization of AUD 1.4 billion. The next major checkpoint is the FY2026 annual result scheduled for November 16, 2026, according to MarketScreener.

First half raised the bar

Elders reported core EBIT of AUD 76.6 million for the first half of FY2026, up 33 percent from the comparable period. Revenue increased 32 percent to AUD 426.4 million, with the Delta Agribusiness acquisition contributing to the expansion, according to Investing.com in its May 18, 2026 earnings summary.

The same first-half summary lists an interim dividend of AUD 0.18 per share and operating cash flow of AUD 67 million. The figures show why the November release matters: the earnings increase must now be weighed against integration and modernization costs in the second half.

Analysts see limited upside

Consensus data compiled by MarketScreener show eight analysts with an average Accumulate rating and an average 12-month price target of AUD 6.56. The target is 3.8 percent above the AUD 6.32 intraday price, using the same currency.

The analyst range is cautious rather than aggressive. FNArena reported on September 23, 2026 that Citi downgraded Elders to Neutral from Buy and set a target of AUD 6.60. Citi identified dry conditions, lower property activity and agricultural input costs as risks heading into FY2027.

Stock remains below its yearly high

Elders stock was trading at AUD 6.32 on the ASX on October 7, 2026 at 10:14 a.m. AEDT, with volume of 739,522 shares. The session range was AUD 6.30 to AUD 6.38, while the 52-week range stood at AUD 4.96 to AUD 7.77.

The current price is 18.7 percent below the 52-week high, leaving the annual result as the next concrete test for whether first-half growth can translate into a stronger second-half valuation. The key variables are Delta integration, system modernization and leverage progress.